According to section 52b subsection 3b of the Medicinal Products Act, the Federal Institute for Drugs and Medical Devices is empowered to set up an Advisory Council to continuously monitor and evaluate the overall supply situation in Germany.

This includes the support of the federal institutes by the members of the council especially in preparing recommendations and evaluation of therapeutic alternatives to improve the supply with medicines for human use.

Members of the Advisory Council according to  section 52b subsection 3b of the Medicinal Products Act are

• Working group of scientific medical societies

  Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. - AWMF

• Drug Commission of German Pharmacists

  Arzneimittelkommission der Deutschen Apotheker - AMK

• Drug Commission of German Doctors

  Arzneimittelkommission der deutschen Ärzteschaft - AkdÄ

• Federal Institutes for Drugs and Medical Devices

  Bundesinstitut für Arzneimittel und Medizinprodukte - BfArM

• Federal Institute for vaccines and biomedicines

  Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel - Paul-Ehrlich-Institut - PEI

• Federal Ministry of Health

  Bundesministerium für Gesundheit - BMG

• German Medicines Manufacturer Association

  Bundesverband der Arzneimittel-Hersteller e.V. - BAH

• Federal Association of the Pharmaceutical Industry e.V

  Bundesverband der Pharmazeutischen Industrie e.V. - BPI

• Federal Assocation of Pharmaceutical Wholesalers e.V.

  Bundesverband des pharmazeutischen Großhandels e.V. - PHAGRO

• The Federal Association of German Hospital Pharmacists

  Bundesverband Deutscher Krankenhausapotheker e.V. - ADKA

• Federal Union of German Associations of Pharmacists

  Bundesvereinigung Deutscher Apothekerverbände - ABDA

• German Hospital Association

  Deutsche Krankenhausgesellschaft e.V. - DKG

• The National Association of Statutory Health Insurance Physicians

  Kassenärztliche Bundesvereinigung - KBV

• Commission for antiinfectives, Resistance and Therapy

  Kommission Antiinfektiva, Resistenz und Therapie - Kommission ART

• Pro Generika e.V.

  Pro Generika e.V.

• National Association of Statutory Health Insurance Funds

  Spitzenverband Bund der Krankenkassen (GKV-Spitzenverband)

• Association of research-based pharmaceutical companies

  Verband Forschender Arzneimittelhersteller e.V. - vfa

• Representative of the interests of the patients

  Vertreter der Interessen der Patientinnen und Patienten - BAG SELBSTHILFE e.V.

• Representatives of the Federal States

  Vertretung der Bundesländer

Protocols and agendas of the meeting are only published in German language.